Exploring new ways to enhance tissue healing through immune system modulation
Designing supramolecular delivery strategies to understand and exploit synergies in immunoregenerative medicine
This study is looking at how special drug delivery methods can help your immune system heal injuries better by focusing on certain immune cells, which could lead to improved treatments for conditions involving tissue damage and inflammation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10890200 on NIH RePORTER |
What this research studies
This research investigates how targeted delivery of therapeutics can influence the immune response to tissue injuries, specifically focusing on the roles of monocytes and macrophages. By designing specialized drug delivery systems, the research aims to promote a healing environment at injury sites, potentially improving recovery outcomes. The approach involves studying how these therapies can alter the communication between immune cells, which is crucial for effective tissue regeneration. Patients may benefit from advancements in treatments for conditions that involve tissue damage and inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from conditions like atherosclerosis, atrophic arthritis, or other inflammatory diseases that affect tissue healing.
Not a fit: Patients with stable, non-inflammatory conditions or those not experiencing tissue injury may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing strategies for patients with various inflammatory diseases and tissue injuries.
How similar studies have performed: Previous research has shown promise in using targeted drug delivery systems to modulate immune responses, indicating potential for success in this novel approach.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rodell, Christopher B — Drexel University
- Study coordinator: Rodell, Christopher B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.